CLINICAL_TRIALS
trial_result
· 2015-12-03
Clinical Trial Update: Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events [Phase 2, Phase 3]
Summary
Phase 2/3 trial investigating aspirin resistance and stroke risk through platelet function analysis in patients with ischemic events.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Stroke, Myocardial Infarctions | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-12-03